— Know what they know.
Not Investment Advice

FUNI OTC

Hypha Labs, Inc.
1W: +0.0% 1M: -13.5% 3M: -67.3% YTD: -87.1%
$0.00
+0.00 (+5.26%)
 
Weekly Expected Move ±58.9%
$-0 $0 $0 $0 $0
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 39 · $737532 mcap · 131M float · 0.199% daily turnover · Short 29% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.7M
52W Range0.0023-0.04
Volume126,997
Avg Volume259,485
Beta1.33
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOA. Stone Douglass
Employees5
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2012-08-13
5940 S. Rainbow Boulevard
Las Vegas, NV 89118
US
702 744 0640
About Hypha Labs, Inc.

Hypha Labs, Inc. focuses on the investigation, development, and market release of bioreactor systems across the United States. Their key offering is the Hypha Micropearl bioreactor, a specialized household device engineered to rapidly cultivate beneficial mushrooms for dietary intake. Founded in 2010, the company is officially based in Las Vegas, Nevada.

Recent Insider Trades

NameTypeSharesPriceDate
DOUGLASS A STONE A-Award 4,000,000 — 2024-02-29
DOUGLASS A STONE A-Award 2,000,000 — 2023-01-18
DOUGLASS A STONE A-Award 1,500,000 — 2021-10-21
DOUGLASS A STONE 1,000,000 $0.06 2021-07-01
Denkin Todd A-Award 1,500,000 — 2021-07-01

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms